122 related articles for article (PubMed ID: 24439918)
1. Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma.
Ni YH; Huang XF; Wang ZY; Han W; Deng RZ; Mou YB; Ding L; Hou YY; Hu QG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):227-33. PubMed ID: 24439918
[TBL] [Abstract][Full Text] [Related]
2. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.
Lin SC; Liu CJ; Lin JA; Chiang WF; Hung PS; Chang KW
Oral Oncol; 2010 Mar; 46(3):204-8. PubMed ID: 20138800
[TBL] [Abstract][Full Text] [Related]
3. [Circular RNA circHIPK3 acts as the sponge of microRNA-124 to promote human oral squamous cell carcinoma cells proliferation].
Wang J; Zhao SY; Ouyang SS; Huang ZK; Luo Q; Liao L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Aug; 53(8):546-551. PubMed ID: 30078268
[No Abstract] [Full Text] [Related]
4. Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.
Ni ZY; Lin FO; Liu DF; Xiao J
Genet Mol Res; 2015 Jun; 14(2):6943-52. PubMed ID: 26125902
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
Li L; Ma HQ
Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells.
Yan B; Fu Q; Lai L; Tao X; Fei Y; Shen J; Chen Z; Wang Q
Mol Med Rep; 2012 Sep; 6(3):675-81. PubMed ID: 22751686
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
8. miR-196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas.
Liu CJ; Tsai MM; Tu HF; Lui MT; Cheng HW; Lin SC
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S406-14. PubMed ID: 23138850
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
[TBL] [Abstract][Full Text] [Related]
10. [Expression of microRNA-31 and its clinicopathologic significance in oral squamous cell carcinoma].
Ouyang SB; Wang J; Huang ZK; Liao L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Aug; 48(8):481-4. PubMed ID: 24238414
[TBL] [Abstract][Full Text] [Related]
11. Plasma miR-187* is a potential biomarker for oral carcinoma.
Liu CJ; Lin JS; Cheng HW; Hsu YH; Cheng CY; Lin SC
Clin Oral Investig; 2017 May; 21(4):1131-1138. PubMed ID: 27324473
[TBL] [Abstract][Full Text] [Related]
12. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
[TBL] [Abstract][Full Text] [Related]
13. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Src homology phosphotyrosyl phosphatase 2 (Shp2) expression in oral cancer and knockdown of Shp2 expression inhibit tumor cell viability and invasion in vitro.
Xie H; Huang S; Li W; Zhao H; Zhang T; Zhang D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):234-42. PubMed ID: 24439919
[TBL] [Abstract][Full Text] [Related]
15. miRNA expression profiles of oral squamous cell carcinomas.
Gombos K; Horváth R; Szele E; Juhász K; Gocze K; Somlai K; Pajkos G; Ember I; Olasz L
Anticancer Res; 2013 Apr; 33(4):1511-7. PubMed ID: 23564792
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro.
Yang X; Wu H; Ling T
Mol Med Rep; 2014 Jul; 10(1):125-30. PubMed ID: 24789258
[TBL] [Abstract][Full Text] [Related]
17. miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.
Yang CJ; Shen WG; Liu CJ; Chen YW; Lu HH; Tsai MM; Lin SC
J Oral Pathol Med; 2011 Aug; 40(7):560-6. PubMed ID: 21226887
[TBL] [Abstract][Full Text] [Related]
18. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer.
Liu CJ; Kao SY; Tu HF; Tsai MM; Chang KW; Lin SC
Oral Dis; 2010 May; 16(4):360-4. PubMed ID: 20233326
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2.
Zeng Q; Tao X; Huang F; Wu T; Wang J; Jiang X; Kuang Z; Cheng B
Int J Mol Med; 2016 May; 37(5):1274-80. PubMed ID: 26986233
[TBL] [Abstract][Full Text] [Related]
20. Annexin A1 down-regulation in oral squamous cell carcinoma correlates to pathological differentiation grade.
Zhu DW; Yang X; Yang CZ; Ma J; Liu Y; Yan M; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
Oral Oncol; 2013 Jun; 49(6):542-50. PubMed ID: 23403091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
